Development and validation of the QUECOMIICAT questionnaire: a tool to assess disease-related knowledge in patients with inflammatory bowel disease
Por:
Casellas, F, Navarro, E, Amil, P, Barber, C, Marin, L, Guardiola, J, Espina, E, Seinz, E, Aldeguer, X, Gallego, M, Murciano, F, Garcia-Planella, E, Martin-de-Carpi, J, Mendive, JM, Gonzalez-Mestre, A
Publicada:
1 ene 2019
Resumen:
Introduction: adequate knowledge of inflammatory bowel disease (IBD) is essential for a successful patient-centered management of IBD.
Objective: due to the scarcity of up-to-date tools for measuring IBD literacy, this single-center, prospective study aimed to develop and validate a new questionnaire to assess IBD-related knowledge.
Material and methods: the study included patients followed up at the Crohn-Colitis Care Unit (UACC) at the Hospital Vall d'Hebron (Barcelona, Spain). Patients admitted to the UACC for the first time were subsequently enrolled into a standard IBD educational program. A pilot questionnaire was developed and validated in 92 IBD patients by determining the internal consistency reliability (Cronbach's alpha test), feasibility, construct validity (correlation with the Crohn's and Colitis Knowledge [CCKNOW] questionnaire and a knowledge visual analog scale [VAS]) and sensitivity (score change before and after a standard IBD educational program). The questionnaire, named "Questionari Coneixements Malaltia Inflamatoria Intestinal Catalunya" (IBD-knowledge questionnaire Catalonia) (QUECOMIICAT) was written in Spanish and had 25 items addressing six dimensions: general concepts, clinic, treatment, surgery, habits and social context.
Results: the median (interquartile range) completion time was 15 (10-20) minutes and the floor and ceiling effects were 1.1% and 2.1%, respectively. The Cronbach's alpha coefficient was alpha = 0.75. QUECOMIICAT significantly correlated with the VAS (rho = 0.34, p < 0.01) and CCKNOW questionnaires (rho = 0.74, p < 0.01). Patient knowledge significantly increased 24 hours after attending a standard IBD educational program and remained statistically significant one month later (Pearson's test-retest correlation coefficient r = 0.81, p < 0.001).
Conclusion: in conclusion, the QUECOMIICAT questionnaire is a new up-to-date tool to assess IBD-related knowledge with good feasibility and validation results for use in the routine clinical practice.
Filiaciones:
Casellas, F:
Hosp Univ Vall dHebron, Crohn Colitis Care Unit, Barcelona, Spain
Navarro, E:
Hosp Univ Vall dHebron, Crohn Colitis Care Unit, Barcelona, Spain
Amil, P:
Generalitat Catalunya, Dept Salut, Direccio Gen Planificacio Salut, Programa Pacient Expert Catalunya,Programa Preven, Barcelona, Spain
Barber, C:
Hosp Univ Vall dHebron, Crohn Colitis Care Unit, Barcelona, Spain
Marin, L:
Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
Guardiola, J:
Hosp Univ Bellvitge, Barcelona, Spain
Espina, E:
Hosp Univ Vall dHebron, Crohn Colitis Care Unit, Barcelona, Spain
Seinz, E:
Hosp Univ Amau Vilanova, Lleida, Spain
Aldeguer, X:
Hosp Univ Doctor Josep Trueta, Girona, Spain
Gallego, M:
Hosp Clin Barcelona, Barcelona, Spain
Murciano, F:
Hosp del Mar Barcelona, Barcelona, Spain
Garcia-Planella, E:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Martin-de-Carpi, J:
Hosp St Joan de Deu, Barcelona, Spain
Mendive, JM:
Gerencia Atencio Primaria Barcelona, SAP LitoraL, CAP Mina, Barcelona, Spain
Gonzalez-Mestre, A:
Generalitat Catalunya, Dept Salut, Direccio Gen Planificacio Salut, Programa Pacient Expert Catalunya,Programa Preven, Barcelona, Spain
Gold
|